TWM
AZN icon

TriaGen Wealth Management’s AstraZeneca AZN Stock Holding History

TriaGen Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,765
Closed -$510K – 161
2024
Q1 		$510K Hold
3,765
– – 0.21% 96
2023
Q4 		$507K Hold
3,765
– – 0.24% 90
2023
Q3 		$510K Hold
3,765
– – 0.26% 88
2023
Q2 		$539K Buy
+3,765
New +$554K 0.25% 96

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TriaGen Wealth Management's AZN Position: Q2 2024 in Review

TriaGen Wealth Management sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 3,765 shares — an estimated $510K sold.

TriaGen Wealth Management first reported a position in AZN in Q2 2023 and held it in 4 quarters. The position peaked at $539K in Q2 2023. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • TriaGen Wealth Management reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • TriaGen Wealth Management sold 3,765 AstraZeneca shares in Q2 2024, an estimated $510K.
  • TriaGen Wealth Management first reported a position in AstraZeneca in Q2 2023 and held it in 4 quarters.
  • TriaGen Wealth Management's AstraZeneca position peaked at $539K in Q2 2023.
  • 1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on TriaGen Wealth Management's 13F filing for Q2 2024, filed 18 Jul 2024.